Sodium 18F-Fluoride Bone Scintigraphy in Deep Ocean Diver

Sodium ¹⁸F-fluoride (NaF) is a diagnostic marker for new bone formation in bone scintigraphy that was approved by US FDA in 1972 but discontinued in 1984. We report a case of a US naval officer who spent time living and working in an oceanic lab, 205 feet below the surface. Plain skeletal films of f...

Full description

Saved in:
Bibliographic Details
Published inClinical nuclear medicine Vol. 40; no. 7; p. 582
Main Authors Lim, Jin T E, Moncayo, Valeria M, Alazraki, Naomi
Format Journal Article
LanguageEnglish
Published United States 01.07.2015
Subjects
Diving - adverse effects
Femur - blood supply
Femur - diagnostic imaging
Fluorine Radioisotopes
Humans
Infarction - diagnostic imaging
Infarction - etiology
Male
Positron-Emission Tomography
Radiopharmaceuticals
Online AccessGet more information

Cover

More Information
Summary:Sodium ¹⁸F-fluoride (NaF) is a diagnostic marker for new bone formation in bone scintigraphy that was approved by US FDA in 1972 but discontinued in 1984. We report a case of a US naval officer who spent time living and working in an oceanic lab, 205 feet below the surface. Plain skeletal films of femurs 4 years later demonstrate bilateral bone infarcts. Corresponding sodium ¹⁸F-fluoride bone scintigraphy demonstrates low-normal to decreased tracer activity. This rectilinear scan image is of historical interest. Other bone scintigraphic radiotracers used in the past and present will be briefly discussed.
ISSN:1536-0229
DOI:10.1097/RLU.0000000000000801